The FDA approved VYALEV for the treatment of motor fluctuations in adults with advanced Parkinson's disease, marking the first subcutaneous 24-hour continuous infusion of levodopa-based therapy approved for this indication.
New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.